Why Most Pharma Giants Are Underestimating the ATMP Commercialization Crisis
The gap between clinical promise and commercial viability in advanced therapy medicinal products is widening faster than most pharmaceutical executives realize, and it’s creating a bifurcated market where early movers capture disproportionate value while late entrants face structural dis
